These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22561214)

  • 1. Botulinum toxin A: dose and immune response.
    Bigalke H; Frevert J
    Int J Rehabil Res; 2012 Jun; 35(2):93. PubMed ID: 22561214
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of total cumulative dose, number of treatment cycles, interval between injections, and length of treatment on the frequency of occurrence of antibodies to botulinum toxin type A in the treatment of muscle spasticity.
    Bakheit AM; Liptrot A; Newton R; Pickett AM
    Int J Rehabil Res; 2012 Mar; 35(1):36-9. PubMed ID: 22108625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective long-term treatment with incobotulinumtoxin (Xeomin®) without neutralizing antibody induction: a monocentric, cross-sectional study.
    Hefter H; Brauns R; Ürer B; Rosenthal D; Albrecht P
    J Neurol; 2020 May; 267(5):1340-1347. PubMed ID: 31960136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
    Dai A
    J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
    [No Abstract]   [Full Text] [Related]  

  • 5. High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?
    Santamato A; Ranieri M; Solfrizzi V; Lozupone M; Vecchio M; Daniele A; Greco A; Seripa D; Logroscino G; Panza F
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):843-6. PubMed ID: 27291256
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications.
    Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Using botulinum toxin (Botox) for treatment of patients with postroke spasticity].
    Khat'kova SE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):87-90. PubMed ID: 19685598
    [No Abstract]   [Full Text] [Related]  

  • 8. Pectoral muscle spasms after mastectomy successfully treated with botulinum toxin injections.
    O'Donnell CJ
    PM R; 2011 Aug; 3(8):781-2. PubMed ID: 21871424
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary.
    Kane MA
    Aesthet Surg J; 2009; 29(5):418-20. PubMed ID: 19825473
    [No Abstract]   [Full Text] [Related]  

  • 10. Spasticity research: some common catches.
    Pandyan AD; Cousins E; van Wijck F; Barnes MP; Johnson GR
    Arch Phys Med Rehabil; 2005 Apr; 86(4):845; author reply 845-6. PubMed ID: 15827943
    [No Abstract]   [Full Text] [Related]  

  • 11. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.
    Bakheit AM; Fedorova NV; Skoromets AA; Timerbaeva SL; Bhakta BB; Coxon L
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1558-61. PubMed ID: 15489387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical resistance to three types of botulinum toxin type A in aesthetic medicine.
    Stephan F; Habre M; Tomb R
    J Cosmet Dermatol; 2014 Dec; 13(4):346-8. PubMed ID: 25399628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of neutralising antibodies in patients treated with botulinum toxin type A for spasticity.
    Müller K; Mix E; Adib Saberi F; Dressler D; Benecke R
    J Neural Transm (Vienna); 2009 May; 116(5):579-85. PubMed ID: 19352590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
    Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
    Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European consensus table on the use of botulinum toxin type A in adult spasticity.
    Wissel J; Ward AB; Erztgaard P; Bensmail D; Hecht MJ; Lejeune TM; Schnider P; Altavista MC; Cavazza S; Deltombe T; Duarte E; Geurts AC; Gracies JM; Haboubi NH; Juan FJ; Kasch H; Kätterer C; Kirazli Y; Manganotti P; Parman Y; Paternostro-Sluga T; Petropoulou K; Prempeh R; Rousseaux M; Slawek J; Tieranta N
    J Rehabil Med; 2009 Jan; 41(1):13-25. PubMed ID: 19197564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
    Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity.
    Ward A; Roberts G; Warner J; Gillard S
    J Rehabil Med; 2005 Jul; 37(4):252-7. PubMed ID: 16024483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevention of pain during botulinum toxin injections in children].
    Gosset B; Dufour E; Jonas MV; Hiriart B; Morelle S; Keirel I; Longue V; Lamy V
    Soins; 2012 Apr; (764):21-4. PubMed ID: 22641937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.